X0508 4 2025-12-31 0001133416 GALECTIN THERAPEUTICS INC GALT 0002032345 Jamil Khurram 4960 PEACHTREE INDUSTRIAL BLVD SUITE 240 NORCROSS GA 30071 false true false false Chief Medical Officer true Common Stock 2025-12-31 4 M false 8125 1.23 A 8125 D Common Stock 2025-12-31 4 S false 8125 4.0725 D 0 D Stock option (right to buy) 1.23 2025-12-31 4 M false 8125 0 D 2025-12-31 2035-01-23 Common Stock 8500 40625 D The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on July 15, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.15. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The options vest as follows: 16,250 on each of June 30, 2025, December 31, 2025, June 30, 2026, and December 31, 2026. Jack W. Callicutt, by power of attorney 2026-01-05